proline and Akinetic-Rigid Variant of Huntington Disease

proline has been researched along with Akinetic-Rigid Variant of Huntington Disease in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19903 (17.65)18.7374
1990's3 (17.65)18.2507
2000's7 (41.18)29.6817
2010's4 (23.53)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindholm, D; Myöhänen, TT; Norrbacka, S1
Lashuel, HA; Lemke, EA; Pappu, RV; Ruff, KM; Tan, PS; Warner, JB1
André, EA; Braatz, EM; Liu, JP; Zeitlin, SO1
Clabough, EB; Neveklovska, M; Steffan, JS; Zeitlin, SO1
Agrawal, N; Cattaneo, E; Illes, K; Lukacsovich, T; Marsh, JL; Pallos, J; Pandolfi, PP; Rockabrand, E; Slepko, N; Steffan, JS; Thompson, LM; Trotman, LC; Zhu, YZ1
Abraham, C; Bauer, B; Buessow, K; Büssow, K; Coleman, SH; Droege, A; Fritzsche, A; Goehler, H; Gutekunst, CA; Haenig, C; Hasenbank, R; Herbst, M; Knoblich, M; Lalowski, M; Landwehrmeyer, BG; Lehrach, H; Lindenberg, KS; Ludewig, AH; Scherzinger, E; Stelzl, U; Stroedicke, M; Suopanki, J; Waelter, S; Wanker, EE; Worm, U1
Baksi, K; Bhattacharyya, NP; Chattopadhyay, B; Mukhopadhyay, S1
Akileswaran, L; Coghlan, VM; Manczak, M; Reddy, PH; Sayer, JA1
Bertolotti, A; Dehay, B1
Kato, Y; Kurita, J; Miyakawa, T; Tanokura, M1
Bertolotti, A; Dehay, B; Trottier, Y; Weber, C1
Allan, BM; Baird, PA; Hansen, S; MacLeod, PM; Perry, TL; Wright, JM1
Blanchard, PJ; Falkous, G; Ishiura, S; Mantle, D; Perry, EK1
Bates, GP; Eickhoff, H; Hasenbank, R; Lehrach, H; Scherzinger, E; Sittler, A; Wälter, S; Wanker, EE; Wedemeyer, N1
Czudek, C; Reynolds, GP1
Diamond, S; Hansen, S; Perry, TL; Stedman, D1
Hansen, S; Lesk, D; Perry, TL1

Trials

1 trial(s) available for proline and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Failure of aminooxyacetic acid therapy in Huntington disease.
    Neurology, 1980, Volume: 30, Issue:7 Pt 1

    Topics: Acetates; Adult; Amino Acids; Aminooxyacetic Acid; Double-Blind Method; Female; Humans; Huntington Disease; Hydroxyproline; Isoniazid; Male; Middle Aged; Ornithine; Proline

1980

Other Studies

16 other study(ies) available for proline and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington's disease.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:12

    Topics: Acetylcysteine; Biocatalysis; Cell Survival; Cysteine Proteinase Inhibitors; HeLa Cells; Humans; Huntingtin Protein; Huntington Disease; Peptides; Proline; Prolyl Oligopeptidases; Proteasome Endopeptidase Complex; Protein Aggregates; Protein Aggregation, Pathological; Serine Endopeptidases; Trinucleotide Repeats

2019
Monomeric Huntingtin Exon 1 Has Similar Overall Structural Features for Wild-Type and Pathological Polyglutamine Lengths.
    Journal of the American Chemical Society, 2017, 10-18, Volume: 139, Issue:41

    Topics: Exons; Fluorescence Resonance Energy Transfer; Humans; Huntingtin Protein; Huntington Disease; Peptides; Proline; Reproducibility of Results

2017
Generation and Characterization of Knock-in Mouse Models Expressing Versions of Huntingtin with Either an N17 or a Combined PolyQ and Proline-Rich Region Deletion.
    Journal of Huntington's disease, 2017, Volume: 6, Issue:1

    Topics: Animals; Autophagy; Brain; Cells, Cultured; Disease Models, Animal; Gene Knock-In Techniques; Huntingtin Protein; Huntington Disease; Male; Maze Learning; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Peptides; Proline; Protein Domains; Sequence Deletion

2017
Deletion of the huntingtin proline-rich region does not significantly affect normal huntingtin function in mice.
    Journal of Huntington's disease, 2012, Volume: 1, Issue:1

    Topics: Amino Acid Sequence; Animals; Base Sequence; Behavior, Animal; Disease Models, Animal; Huntingtin Protein; Huntington Disease; Intracellular Space; Mice; Mice, Transgenic; Molecular Sequence Data; Nerve Tissue Proteins; Nuclear Proteins; Phosphorylation; Proline; Proline-Rich Protein Domains; Sequence Deletion

2012
SUMO modification of Huntingtin and Huntington's disease pathology.
    Science (New York, N.Y.), 2004, Apr-02, Volume: 304, Issue:5667

    Topics: Animals; Animals, Genetically Modified; Cell Line; Cell Nucleus; Corpus Striatum; Cytoplasm; Drosophila; Genes, MDR; HeLa Cells; Humans; Huntingtin Protein; Huntington Disease; Lysine; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Proline; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; SUMO-1 Protein; Transcription, Genetic; Transfection; Ubiquitin

2004
A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.
    Molecular cell, 2004, Sep-24, Volume: 15, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Binding Sites; Cell Cycle Proteins; Chlorocebus aethiops; COS Cells; Glutathione; GTPase-Activating Proteins; Humans; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Nerve Tissue Proteins; Nuclear Proteins; PC12 Cells; Phosphoproteins; Precipitin Tests; Proline; Protein Binding; Protein Structure, Tertiary; Rats; Recombinant Fusion Proteins; RNA Interference; Tissue Distribution; Two-Hybrid System Techniques

2004
Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
    Neuroscience letters, 2005, Feb-10, Volume: 374, Issue:2

    Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Arginine; Deoxyribonucleases; Female; Genetic Variation; Genotype; Glucan 1,3-beta-Glucosidase; Humans; Huntington Disease; Lysine; Male; Odds Ratio; Poly-ADP-Ribose Binding Proteins; Polymorphism, Single Nucleotide; Proline; Trinucleotide Repeat Expansion; Tumor Suppressor Protein p53

2005
Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.
    Neuromolecular medicine, 2005, Volume: 7, Issue:4

    Topics: Aged; Animals; Brain; Cell Line; Cell Nucleus; Female; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Middle Aged; Mutation; Nerve Tissue Proteins; Neurons; Nuclear Matrix; Nuclear Matrix-Associated Proteins; Nuclear Proteins; Peptides; Proline; Protein Binding; Protein Structure, Tertiary; Two-Hybrid System Techniques

2005
Critical role of the proline-rich region in Huntingtin for aggregation and cytotoxicity in yeast.
    The Journal of biological chemistry, 2006, Nov-24, Volume: 281, Issue:47

    Topics: Centrifugation, Density Gradient; Formates; Gene Deletion; Green Fluorescent Proteins; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Huntingtin Protein; Huntington Disease; Microscopy, Fluorescence; Molecular Chaperones; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Proline; Protein Binding; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sucrose

2006
Structure of FBP11 WW1-PL ligand complex reveals the mechanism of proline-rich ligand recognition by group II/III WW domains.
    The Journal of biological chemistry, 2006, Dec-29, Volume: 281, Issue:52

    Topics: Amino Acid Motifs; Carrier Proteins; Humans; Huntington Disease; Leucine; Ligands; Magnetic Resonance Spectroscopy; Peptides; Proline; Proline-Rich Protein Domains; Protein Structure, Tertiary; Rett Syndrome; Ribonucleoprotein, U1 Small Nuclear; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Tryptophan

2006
Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicity.
    Biotechnology journal, 2007, Volume: 2, Issue:5

    Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Dimerization; Epitope Mapping; Humans; Huntingtin Protein; Huntington Disease; Mice; Molecular Sequence Data; Nerve Tissue Proteins; Nuclear Proteins; Proline; Protein Structure, Tertiary; Structure-Activity Relationship

2007
Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
    Clinica chimica acta; international journal of clinical chemistry, 1996, May-30, Volume: 249, Issue:1-2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Dementia; Female; Humans; Huntington Disease; Lewy Bodies; Male; Parkinson Disease; Proline; Prolyl Oligopeptidases; Serine Endopeptidases; Tissue Distribution

1996
SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates.
    Molecular cell, 1998, Volume: 2, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Animals; Brain Chemistry; Carrier Proteins; COS Cells; Exons; Gene Expression; Glutamine; Humans; Huntingtin Protein; Huntington Disease; Nerve Tissue Proteins; Nuclear Proteins; Peptide Fragments; Precipitin Tests; Proline; Rabbits; Repetitive Sequences, Nucleic Acid; RNA, Messenger; src Homology Domains; Subcellular Fractions; Yeasts

1998
[3H]nipecotic acid binding to gamma-aminobutyric acid uptake sites in postmortem human brain.
    Journal of neurochemistry, 1990, Volume: 55, Issue:1

    Topics: Aged; Aging; Binding Sites; Brain; Cadaver; Female; gamma-Aminobutyric Acid; Hippocampus; Humans; Huntington Disease; Male; Middle Aged; Nipecotic Acids; Postmortem Changes; Proline; Sodium; Tritium

1990
Plasma-aminoacid levels in Huntington's chorea.
    Lancet (London, England), 1969, Apr-19, Volume: 1, Issue:7599

    Topics: Adult; Alanine; Amino Acids; Female; Humans; Huntington Disease; Isoleucine; Leucine; Male; Middle Aged; Proline; Schizophrenia; Tyrosine; Valine

1969
[Plasma amino acid levels in children of patients with Huntington's chorea].
    Neurology, 1972, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Alanine; Amino Acids; Child; Child, Preschool; Female; Humans; Huntington Disease; Isoleucine; Leucine; Male; Middle Aged; Proline; Schizophrenia; Tyrosine

1972